Home versus hospital intravenous antibiotic therapy for cystic fibrosis - Wikidata - awgldk - TriplyDB

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

http://www.wikidata.org/entity/Q24187116

about

Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit.

P2860

Q37413404-7C8ACC81-0F44-4E06-BFD1-DB1E26566F2E Q49445774-B5B6034E-236D-4174-96E6-0CC576838070

P2860

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

http://www.wikidata.org/entity/Q24187116

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@ast

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en-gb

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@nl

type

label

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@ast

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en-gb

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@nl

prefLabel

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@ast

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en-gb

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@nl

P1433

Q24187116-3ED73A51-5CB2-4C8A-9928-B9D6CE0E6748

P1476

Q24187116-1D9ECE1A-7DD9-4DD0-8F22-5C5146A19372

P2093

Q24187116-41C60C21-1564-453D-A070-9F83E8616CE3

Q24187116-84F705A0-3CA6-4955-BA7F-1218FC3CD000

P2860

Q24187116-1D57657E-30EF-476B-9183-E7F30B60833A

Q24187116-246ACEEA-E858-449A-81C0-BBF68C1C5C28

Q24187116-2B7CC8A3-430E-4163-AACB-C46F7384A039

Q24187116-3A50440A-3722-48A7-858E-C4EFCC20096A

Q24187116-408E8214-E646-4476-9F35-DE506FEF64CE

Q24187116-4305D732-578E-465C-91DB-F7A33424E62D

Q24187116-45B8E350-798F-418D-A847-CED771355C0B

Q24187116-477B7ED2-FAEB-4BA7-980F-E80F55F40F5F

Q24187116-4F8B86E8-926B-43D5-9099-C1F5F90859E7

Q24187116-639BDDA6-6257-4DD4-864E-F890D9CFF57E

P304

Q24187116-49647836-8606-42D8-9FEA-439648416189

P31

Q24187116-8a88a1f5-f3a8-4eee-a3de-7ab359e8ad2a

Q24187116-A9339421-08BE-42CF-B219-8B9BA0D0F4FB

P356

Q24187116-F842BFCA-D60A-408F-A947-F220DBAE5674

P433

Q24187116-8CEDEB32-66C0-4CBE-B0FF-566C35949AB9

P50

Q24187116-D8A127A4-FFB2-4E89-8A23-B412E4854B23

P577

Q24187116-6B03B83F-0DA6-4CD0-8467-66972EEB4E27

P698

Q24187116-5148E869-96AD-45D1-AD6A-DDB44630389A

P921

Q24187116-3BDCD214-2820-4516-8761-820DD44E411D

P932

Q24187116-8D347C71-3DA3-4A3F-BAD2-E3F3AB4B83B6

P356

14651858.CD001917.PUB4

P1433

Cochrane Database of Systematic Reviews

P1476

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

@en

P2093

Albert Balaguer

http://www.w3.org/2001/XMLSchema#string

Javier González de Dios

http://www.w3.org/2001/XMLSchema#string

P2860

Home versus hospital intravenous antibiotic therapy for cystic fibrosis

Admission avoidance hospital at home

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Meta-analysis in clinical trials

Systematic reviews in health care: Assessing the quality of controlled clinical trials

Home intravenous antibiotics for cystic fibrosis.

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

Location and duration of treatment of cystic fibrosis respiratory exacerbations do not affect outcomes.

P304

CD001917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD001917.PUB4

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P50

Albert Balaguer

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26671062

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

6481823

http://www.w3.org/2001/XMLSchema#string